CRANBURY, N.J.--(BUSINESS WIRE)--Innophos Holdings, Inc., a leading international producer of essential ingredients, today announced the launch of Oxyjun® Terminalia arjuna aqueous extract, expanding its portfolio of targeted sports performance and active nutrition ingredients.
Clinically studied Oxyjun® arjuna extract, a matrix of bioactives including polyphenols and glycosides, has demonstrated advanced benefits, which include its ability to help support heart health and enhance sports performance in young, healthy exercising adults.* Oxyjun® is prepared using a proprietary manufacturing process and is water soluble, stimulant free, vegetarian, and suitable for a wide range of applications.
“We are excited to add clinically studied Oxyjun® arjuna extract to Innophos’ diverse portfolio of specialty ingredients," said Dr. Bruce Abedon, Lead Scientist in Innophos’s botanical ingredient solutions group. He added, “Oxyjun® complements our sports performance solutions and brings important cardio and endurance benefits to young, healthy exercising adults. Active consumers are seeking high value, clean label products to support their healthy lifestyles and achieve peak results that Oxyjun® delivers.”
* These statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat, cure, or prevent any disease.
About the Company
Innophos is a leading international producer of essential ingredients. We partner with world-leading health & nutrition, food & beverage and industrial brands to create science-based solutions that improve quality of life. Our knowledgeable teams apply science to unlock the potential that lies within the blends and formulations that we deliver. Forward thinking and people centric at heart, we execute with purpose and efficiency to create value in everything we do. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information, please visit www.innophos.com